Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
301087 Cofoe Medical Technology
- 39.39
- +1.27+3.33%
Market Closed Dec 12 15:00 CST
8.24BMarket Cap31.16P/E (TTM)
39.45High37.95Low27.33KlotVolume38.11Open38.12Pre Close106.74MTurnover3.02%Turnover Ratio32.39P/E (Static)209.09MShares46.9252wk High1.74P/B3.57BFloat Cap23.7552wk Low45.74Limit Up90.57MShs Float68.92Historical High30.50Limit Down3.94%Amplitude23.75Historical Low1.80Dividend TTM39.05Avg Price10.86KlotAsk4.57%Div YieldTTM100Lot Size15.44KlotBid
Cofoe Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 54.97%1.82B | 49.02%1.79B | 23.37%1.75B | 8.24%1.57B | -8.98%1.18B | -12.61%1.2B | -21.06%1.42B | -27.11%1.45B | 948.57%1.29B | 573.42%1.37B |
| Transactional financial assets | -36.89%840.17M | -46.23%709.74M | -31.59%858.84M | -31.54%851.3M | -12.40%1.33B | -12.71%1.32B | -15.42%1.26B | -19.12%1.24B | --1.52B | --1.51B |
| Notes receivable and accounts receivable | -13.76%395.85M | -3.27%440.87M | 2.17%475.51M | -16.17%474.73M | 13.18%459M | -6.56%455.76M | 1.94%465.42M | 63.57%566.27M | 23.91%405.54M | 102.16%487.75M |
| -Notes receivable | --178.36K | --119.91K | ---- | --632.75K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Accounts receivable | -13.80%395.67M | -3.29%440.75M | 2.17%475.51M | -16.28%474.1M | 13.18%459M | -6.56%455.76M | 1.94%465.42M | 63.57%566.27M | 23.91%405.54M | 102.16%487.75M |
| Other receivables (including interest and dividends) | 68.66%69.78M | 61.01%51.69M | 46.80%60.85M | 36.38%58M | 13.16%41.37M | -37.29%32.11M | 24.63%41.45M | 68.80%42.53M | -36.44%36.56M | 13.46%51.19M |
| -Other receivable | ---- | 61.01%51.69M | ---- | ---- | ---- | -37.29%32.11M | ---- | 68.80%42.53M | ---- | 13.46%51.19M |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Advance payment | -12.42%131.84M | 8.82%133.05M | -23.28%121.11M | -47.54%131.08M | 52.65%150.53M | 45.58%122.27M | 5.91%157.86M | 272.90%249.83M | -2.47%98.61M | 29.79%83.99M |
| Inventories | 11.63%683.02M | 10.12%682.69M | -12.55%607.04M | 19.90%634.72M | 17.16%611.86M | 12.28%619.96M | 22.48%694.17M | 10.11%529.36M | 29.65%522.23M | 26.10%552.15M |
| Receivable financing | -45.72%12.18M | -58.70%14.08M | -41.45%26.28M | -77.88%11.27M | 64.54%22.45M | 193.40%34.1M | 605.60%44.89M | 222.09%50.95M | 66.10%13.64M | 2.00%11.62M |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other current assets | -39.24%56.53M | 26.61%70.26M | 13.53%76.79M | 46.47%100.22M | 26.36%93.04M | -15.66%55.49M | 9.23%67.63M | 19.33%68.42M | 138.50%73.63M | 142.47%65.79M |
| Total current assets | 3.24%4.01B | 1.31%3.89B | -4.08%3.98B | -8.81%3.83B | -1.93%3.88B | -7.21%3.84B | -9.00%4.14B | -7.04%4.2B | 276.90%3.96B | 301.11%4.14B |
| Non Current assets | ||||||||||
| Investment real estate | --10.49M | --10.67M | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Long-term equity investment | 1,165.27%65.39M | 1,148.57%64.82M | 1,129.83%64.49M | 1,135.26%64.93M | -1.54%5.17M | -2.09%5.19M | -0.97%5.24M | -0.40%5.26M | -2.57%5.25M | 10.82%5.3M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Fixed assets | ---- | 10.10%1.51B | ---- | ---- | ---- | 500.00%1.37B | ---- | 502.65%1.29B | ---- | 20.74%227.94M |
| Constru in process | ---- | -34.99%66.66M | ---- | ---- | ---- | -87.74%102.54M | ---- | -66.29%171.39M | ---- | 312.96%836.18M |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Intangible assets | -3.82%236.79M | -2.71%237.94M | -3.07%238.82M | -3.10%240.55M | 2.38%246.18M | 1.24%244.56M | 2.54%246.38M | 22.73%248.25M | 20.37%240.47M | 20.11%241.56M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.5M | --5.72M |
| Goodwill | 51.21%363.72M | 57.80%363.72M | 42.33%328.06M | 5.17%242.41M | 5.09%240.55M | 0.70%230.5M | 253.28%230.5M | 374.36%230.5M | 1,872.94%228.89M | 1,872.94%228.89M |
| Long deferred expense | -18.08%46.27M | -12.20%49.9M | -3.66%53.21M | -15.57%50.92M | 38.54%56.48M | 30.05%56.83M | 18.40%55.23M | 26.31%60.32M | 33.36%40.77M | 29.49%43.7M |
| Deferred tax assets | 42.33%51.57M | 40.44%43.17M | 10.79%36.56M | 10.53%34.72M | 79.34%36.24M | 60.75%30.74M | 85.12%33M | 149.22%31.42M | 77.66%20.21M | 91.12%19.12M |
| Usufruct assets | -2.39%132.02M | 7.42%131.2M | 4.32%139.12M | 1.63%138.99M | -20.96%135.25M | -37.82%122.13M | -32.24%133.35M | -12.95%136.76M | 83.42%171.11M | 109.19%196.4M |
| Other non current assets | -76.41%12.02M | -51.86%28.56M | -26.10%30.01M | 134.00%84.11M | -26.81%50.94M | 64.39%59.33M | 60.02%40.6M | -60.96%35.95M | 8.46%69.6M | 32.09%36.09M |
| Total non current assets | 7.49%2.46B | 12.75%2.5B | 11.94%2.48B | 9.20%2.41B | 9.35%2.29B | 20.56%2.22B | 38.64%2.22B | 71.56%2.21B | 129.72%2.1B | 137.92%1.84B |
| Total assets | 4.82%6.47B | 5.50%6.39B | 1.50%6.46B | -2.60%6.24B | 1.98%6.18B | 1.35%6.06B | 3.38%6.36B | 10.40%6.41B | 208.51%6.06B | 231.15%5.98B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 70.06%557.5M | 49.75%459.25M | 18.94%339.19M | 43.24%402.43M | -11.61%327.83M | -16.70%306.68M | -19.68%285.18M | 238.18%280.94M | 437.53%370.9M | 1,127.23%368.17M |
| Notes payable and accounts payable | -1.34%452.66M | 10.87%522.98M | -5.97%521.73M | -23.93%482.97M | 4.04%458.8M | 35.46%471.7M | 34.59%554.84M | 41.68%634.89M | 25.73%440.98M | 5.47%348.23M |
| -Notes payable | 56.02%113.64M | -10.35%72.79M | 2.29%95.12M | -0.80%85.66M | 59.17%72.84M | 24.12%81.19M | -10.07%93M | -37.58%86.36M | -63.90%45.76M | -43.16%65.41M |
| -Accounts payable | -12.16%339.02M | 15.28%450.19M | -7.63%426.61M | -27.57%397.31M | -2.34%385.96M | 38.08%390.51M | 49.54%461.84M | 77.09%548.53M | 76.47%395.22M | 31.48%282.81M |
| Contract liabilities | 648.12%3.03M | 888.09%3.1M | -26.77%2.79M | 9.92%2.8M | -57.11%405.35K | -67.77%314.08K | 654.14%3.81M | 58.79%2.55M | --945.13K | 320.14%974.43K |
| Advance receipts | 59.10%24.86M | 141.38%22.29M | 53.16%17.7M | 118.37%14.04M | 129.17%15.63M | 33.80%9.23M | 48.68%11.56M | -23.44%6.43M | 390.19%6.82M | 303.32%6.9M |
| Salaries payable | 34.96%37.85M | 20.43%36.87M | 14.54%37M | 1.56%49.57M | -0.80%28.04M | -1.13%30.62M | 22.88%32.31M | 96.56%48.81M | 61.43%28.27M | 89.62%30.97M |
| Taxs payable | -27.82%27.44M | 148.48%26.91M | -26.90%28.39M | -78.72%15.83M | 47.78%38.01M | -68.34%10.83M | 55.55%38.83M | 107.30%74.38M | -11.55%25.72M | 31.82%34.21M |
| Other payable (including interest and dividends) | 114.56%177.35M | 2.32%61.07M | -4.92%61.11M | -25.69%51.07M | 49.96%82.66M | -10.02%59.69M | 40.80%64.28M | 138.56%68.73M | 86.23%55.12M | 208.39%66.33M |
| -Dividend payable | --122.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 2.32%61.07M | ---- | ---- | ---- | -10.02%59.69M | ---- | 138.56%68.73M | ---- | 208.89%66.33M |
| Non current liabilities due within one year | 134.42%143.7M | 129.11%147.71M | 135.06%147.81M | -4.96%67.01M | 6.60%61.3M | -14.10%64.47M | 4.37%62.88M | 35.88%70.5M | 180.66%57.5M | 97.38%75.05M |
| Other current liabilities | 3,531.73%187.74K | 1,119.10%126.23K | ---- | 86.54%684.04K | -91.81%5.17K | -60.93%10.35K | 179,107.91%490.69K | 6,346.73%366.7K | --63.14K | -12.09%26.5K |
| Total current liabilities | 40.68%1.42B | 34.27%1.28B | 9.63%1.16B | -8.52%1.09B | 2.67%1.01B | 2.44%953.55M | 13.02%1.05B | 73.98%1.19B | 90.48%986.32M | 100.63%930.86M |
| Current liabilities | ||||||||||
| Long term loan | 51.98%146.67M | 56.69%155.12M | 51.04%160.1M | 213.37%94.1M | --96.5M | --99M | --106M | --30.03M | ---- | ---- |
| Long term account payable | ---- | -1.13%6.66M | ---- | ---- | ---- | -42.62%6.73M | ---- | 48.12%7.41M | ---- | 17.32%11.73M |
| Estimate liabilities | --85K | --85K | --210.56K | --210.56K | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -35.12%15.54M | -41.89%11.89M | -15.33%15.04M | -5.86%15.7M | 159.62%23.95M | 155.07%20.46M | 195.76%17.77M | 282.35%16.68M | 167.56%9.23M | 126.06%8.02M |
| Long term deferred income | 0.35%55.76M | 1.29%56.12M | 6.02%56.5M | 7.58%55.62M | -1.12%55.57M | -2.29%55.41M | -6.87%53.29M | -9.05%51.7M | 0.03%56.2M | 0.11%56.71M |
| Lease liabilities | -1.92%76.26M | 4.07%68.28M | -10.50%79.26M | -8.65%77.24M | -22.57%77.75M | -45.06%65.61M | -30.59%88.56M | -9.27%84.55M | 32.13%100.41M | 100.72%119.42M |
| Total non current liabilities | 15.53%300.98M | 20.61%298.15M | 16.68%317.77M | 31.12%249.6M | 46.71%260.51M | 26.20%247.21M | 39.08%272.35M | 19.43%190.36M | 21.94%177.57M | 51.04%195.88M |
| Total liabilities | 35.53%1.73B | 31.46%1.58B | 11.08%1.47B | -3.04%1.34B | 9.39%1.27B | 6.57%1.2B | 17.54%1.33B | 63.66%1.38B | 75.44%1.16B | 89.80%1.13B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.29%209.09M | 0.36%209.24M | 0.36%209.24M | 0.36%209.24M | 0.00%208.49M | 0.00%208.49M | 30.00%208.49M | 30.30%208.49M | 73.74%208.49M | 73.74%208.49M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Capital reserve funds | 0.40%3.94B | 0.69%3.95B | 0.59%3.94B | 0.53%3.93B | 0.41%3.92B | 0.51%3.92B | -0.70%3.91B | -0.12%3.91B | 806.91%3.91B | 805.32%3.9B |
| Surplus reserve funds | 44.18%111.57M | 44.18%111.57M | 22.46%94.76M | 22.46%94.76M | 27.97%77.38M | 27.97%77.38M | 27.97%77.38M | 27.97%77.38M | 74.03%60.47M | 74.03%60.47M |
| Retained profit | -16.36%697.27M | -4.84%752.37M | -4.34%929.86M | -1.06%828.64M | 15.76%833.69M | 15.77%790.65M | 13.09%972.02M | 3.48%837.5M | 1.35%720.22M | 9.84%682.97M |
| Less:Treasury stock | 39.78%212.55M | 42.66%216.93M | 32.38%196.32M | 960.64%166.93M | 866.12%152.06M | 866.12%152.06M | 807.69%148.3M | --15.74M | --15.74M | --15.74M |
| Other composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Shareholders equity without minority interests | -3.00%4.74B | -0.85%4.8B | -0.97%4.97B | -2.41%4.9B | 0.21%4.89B | 0.17%4.84B | 0.36%5.02B | 1.48%5.02B | 276.49%4.88B | 300.53%4.84B |
| Minority interests | -60.20%5.49M | -24.38%10.12M | -23.61%8.73M | -28.39%9M | 1.80%13.79M | -11.00%13.39M | -41.42%11.43M | -29.96%12.57M | 254.82%13.55M | 273.24%15.04M |
| Total shareholder equity | -3.16%4.75B | -0.91%4.81B | -1.03%4.98B | -2.48%4.91B | 0.21%4.9B | 0.13%4.86B | 0.20%5.03B | 1.36%5.03B | 276.42%4.89B | 300.44%4.85B |
| Total liabilityies and equity | 4.82%6.47B | 5.50%6.39B | 1.50%6.46B | -2.60%6.24B | 1.98%6.18B | 1.35%6.06B | 3.38%6.36B | 10.40%6.41B | 208.51%6.06B | 231.15%5.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
